Search Results - "EE Langton"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Suspected Malignant Hyperthermia reactions in New Zealand by POLLOCK, A. N, LANGTON, E. E, COUCHMAN, K, STOWELL, K. M, WADDINGTON, M

    Published in Anaesthesia and intensive care (01-08-2002)
    “…Early clinical signs, triggering agents, time to onset of reaction, mortality and methods of treatment were identified in 123 suspected malignant hyperthermia…”
    Get full text
    Journal Article
  2. 2

    Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibilityidentified: Missed opportunities prior to diagnosis by TY Chan, TF Bulger, KM Stowell, RL Gillies, EE Langton, NE Street, NA Pollock

    Published in Anaesthesia and intensive care (01-11-2017)
    “…Malignant hyperthermia (MH) is a hypermetabolic disorder of skeletal muscle triggered almost exclusively by potent inhalational agents and suxamethonium. Signs…”
    Get full text
    Journal Article
  3. 3

    Management of malignant hyperthermia susceptible parturients by POLLOCK, N. A, LANGTON, E. E

    Published in Anaesthesia and intensive care (01-08-1997)
    “…The management of eleven women susceptible to malignant hyperthermia during twenty deliveries is presented. These women were managed over a six-year period…”
    Get full text
    Journal Article
  4. 4

    Administration of anaesthetic triggering agents to patients tested malignant hyperthermia normal and their relatives in New Zealand: An update by Frei, D., Stowell, K. M., Langton, E. E., McRedmond, L., Pollock, N. A., Bulger, T. F.

    Published in Anaesthesia and intensive care (01-09-2017)
    “…Testing for malignant hyperthermia in New Zealand involves two tests-in vitro contracture testing of excised lateral quadriceps muscle and DNA analysis. In…”
    Get full text
    Journal Article